Josh Chatelier

Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells

Emily SJ Edwards, Julian J Bosco, Pei M Aui, Robert G Stirling, Paul U Cameron, Josh Chatelier, Fiona Hore-Lacy, Robyn E O'Hehir, Menno C van Zelm

Journal article  |  2019  |  FRONTIERS IN IMMUNOLOGY

Background: Patients with predominantly antibody deficiency (PAD) suffer from severe and recurrent infections that require lifelon..

Modulation of soluble and particulate antigen transport in afferent lymph by monophosphoryl lipid A.

Michael de Veer, Joanna Kemp, Josh Chatelier, Martin J Elhay, Els NT Meeusen

Journal article  |  2012  |  Immunol Cell Biol

Vaccine adjuvants stimulate the innate immune system and determine the outcome of the immune response induced. A better understand..

The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant.

Michael de Veer, Joanna Kemp, Josh Chatelier, Martin J Elhay, Els NT Meeusen

Journal article  |  2010  |  Vaccine

Aluminium adjuvants are potent enhancers of immune responses. Despite being a component in most human and animal vaccines, their s..